Difference between revisions of "Tian X, et al. Hum. Vaccin. Immunother. (2013) cited as Ref 547 in DOI: 10.1038/s41392-020-0110-5 (Q9810)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 23108359, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Page(s) (P105): 222-225, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
(4 intermediate revisions by the same user not shown) | |||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2013
| ||||||||||||||
Property / Publication Date: 2013 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Published In Name String | |||||||||||||||
+ | Hum. Vaccin. Immunother. | ||||||||||||||
Property / Published In Name String: Hum. Vaccin. Immunother. / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Volume | |||||||||||||||
+ | 9 | ||||||||||||||
Property / Volume: 9 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / title | |||||||||||||||
+ | How can nanotechnology help membrane vesicle-based cancer immunotherapy development? (English) | ||||||||||||||
Property / title: How can nanotechnology help membrane vesicle-based cancer immunotherapy development? (English) / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Page(s) | |||||||||||||||
+ | 222-225 | ||||||||||||||
Property / Page(s): 222-225 / rank | |||||||||||||||
+ | Normal rank |
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Tian X, et al. Hum. Vaccin. Immunother. (2013) cited as Ref 547 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Tian X
0 references
Zhu M
0 references
Nie G
0 references
2013
0 references
Hum. Vaccin. Immunother.
0 references
9
0 references
How can nanotechnology help membrane vesicle-based cancer immunotherapy development? (English)
0 references
222-225
0 references